Pulsar Helium Inc. (AIM: PLSR, TSXV: PLSR, OTCQB: PSRHF) has announced the results of an independent Pre-Feasibility Study ...
Background: Determining optimal timing for intensifying the frequency of physician encounters for type 2 diabetes mellitus (T2DM) requires trade-offs between timely care and clinician burden. We aimed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback